Imatinib mesylate
GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 19 | 3.0 | 2.4 | 0.6 | 0.1 | -1.605 | 0.2442 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
2 | 9429 | 2.8 | 6.4 | 0.5 | 0.3 | 11.391 | 0.0013 | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) |
3 | 53 | 7.1 | 6.8 | 0.3 | 0.3 | -1.081 | 0.3404 | ACP2 | acid phosphatase 2, lysosomal |
4 | 183 | 2.4 | 2.4 | 0.1 | 0.0 | -1.120 | 0.3647 | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
5 | 196 | 9.6 | 8.4 | 0.3 | 0.2 | -6.697 | 0.0045 | AHR | aryl hydrocarbon receptor |
6 | 213 | 3.2 | 2.8 | 0.4 | 0.5 | -1.148 | 0.3190 | ALB | albumin |
7 | 238 | 2.5 | 2.5 | 0.1 | 0.1 | 0.197 | 0.8553 | ALK | anaplastic lymphoma receptor tyrosine kinase |
8 | 55107 | 2.6 | 2.8 | 0.4 | 0.6 | 0.305 | 0.7783 | ANO1 | anoctamin 1, calcium activated chloride channel |
9 | 351 | 10.8 | 10.5 | 0.1 | 0.3 | -1.679 | 0.1960 | APP | amyloid beta (A4) precursor protein |
10 | 9138 | 6.7 | 6.9 | 0.4 | 0.1 | 0.643 | 0.5800 | ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 |
11 | 347527 | 2.5 | 2.8 | 0.1 | 0.4 | 1.098 | 0.3784 | ARSH | arylsulfatase family, member H |
12 | 443 | 2.4 | 2.6 | 0.0 | 0.2 | 1.598 | 0.2367 | ASPA | aspartoacylase |
13 | 1822 | 10.5 | 10.7 | 0.2 | 0.1 | 1.880 | 0.1334 | ATN1 | atrophin 1 |
14 | 51761 | 2.8 | 4.2 | 0.2 | 0.2 | 8.068 | 0.0017 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
15 | 9212 | 8.7 | 10.0 | 0.2 | 0.2 | 7.824 | 0.0014 | AURKB | aurora kinase B |
16 | 6795 | 2.3 | 2.2 | 0.1 | 0.0 | -0.879 | 0.4595 | AURKC | aurora kinase C |
17 | 158835 | 3.4 | 2.3 | 1.9 | 0.0 | -0.989 | 0.4269 | AWAT2 | acyl-CoA wax alcohol acyltransferase 2 |
18 | 27241 | 6.8 | 6.8 | 0.6 | 0.7 | 0.060 | 0.9553 | BBS9 | Bardet-Biedl syndrome 9 |
19 | 596 | 10.3 | 10.3 | 0.2 | 0.1 | 0.739 | 0.5268 | BCL2 | B-cell CLL/lymphoma 2 |
20 | 598 | 8.1 | 7.7 | 0.2 | 0.1 | -2.960 | 0.0676 | BCL2L1 | BCL2-like 1 |
21 | 613 | 9.2 | 9.2 | 0.2 | 0.1 | -0.129 | 0.9051 | BCR | breakpoint cluster region |
22 | 8678 | 12.2 | 11.6 | 0.1 | 0.1 | -10.006 | 0.0008 | BECN1 | beclin 1, autophagy related |
23 | 672 | 9.9 | 10.0 | 0.0 | 0.4 | 0.374 | 0.7433 | BRCA1 | breast cancer 1, early onset |
24 | 83990 | 10.5 | 11.4 | 0.3 | 0.7 | 2.104 | 0.1282 | BRIP1 | BRCA1 interacting protein C-terminal helicase 1 |
25 | 695 | 2.9 | 3.1 | 0.0 | 1.2 | 0.253 | 0.8241 | BTK | Bruton agammaglobulinemia tyrosine kinase |
26 | 78996 | 9.9 | 11.0 | 0.2 | 0.1 | 9.881 | 0.0048 | C7orf49 | chromosome 7 open reading frame 49 |
27 | 836 | 8.2 | 8.0 | 0.3 | 0.2 | -1.211 | 0.3082 | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
28 | 841 | 5.6 | 6.3 | 0.3 | 0.2 | 2.697 | 0.0646 | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
29 | 842 | 8.6 | 7.7 | 0.1 | 0.6 | -2.444 | 0.1304 | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
30 | 947 | 2.6 | 2.4 | 0.1 | 0.1 | -2.834 | 0.0480 | CD34 | CD34 molecule |
31 | 920 | 12.3 | 12.1 | 0.1 | 0.3 | -1.157 | 0.3384 | CD4 | CD4 molecule |
32 | 960 | 13.9 | 11.7 | 0.4 | 0.2 | -8.327 | 0.0057 | CD44 | CD44 molecule (Indian blood group) |
33 | 925 | 7.3 | 6.8 | 0.1 | 0.0 | -6.573 | 0.0181 | CD8A | CD8a molecule |
34 | 1000 | 3.2 | 3.2 | 0.4 | 0.1 | 0.188 | 0.8677 | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) |
35 | 1019 | 14.3 | 14.4 | 0.2 | 0.1 | 0.678 | 0.5498 | CDK4 | cyclin-dependent kinase 4 |
36 | 1029 | 6.0 | 6.5 | 0.4 | 0.0 | 2.330 | 0.1427 | CDKN2A | cyclin-dependent kinase inhibitor 2A |
37 | 81620 | 13.0 | 13.5 | 0.6 | 0.1 | 1.278 | 0.3241 | CDT1 | chromatin licensing and DNA replication factor 1 |
38 | 634 | 3.2 | 3.3 | 0.5 | 0.1 | 0.339 | 0.7645 | CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
39 | 10153 | 11.0 | 11.1 | 0.2 | 0.1 | 0.563 | 0.6055 | CEBPZ | CCAAT/enhancer binding protein (C/EBP), zeta |
40 | 1268 | 2.2 | 2.4 | 0.0 | 0.1 | 1.848 | 0.2050 | CNR1 | cannabinoid receptor 1 (brain) |
41 | 8506 | 6.1 | 6.0 | 0.1 | 0.2 | -0.537 | 0.6258 | CNTNAP1 | contactin associated protein 1 |
42 | 83548 | 10.1 | 10.1 | 0.0 | 0.2 | 0.698 | 0.5574 | COG3 | component of oligomeric golgi complex 3 |
43 | 341947 | 2.8 | 3.0 | 0.2 | 0.3 | 1.353 | 0.2543 | COX8C | cytochrome c oxidase subunit VIIIC |
44 | 1378 | 2.7 | 2.3 | 0.8 | 0.0 | -0.979 | 0.4301 | CR1 | complement component (3b/4b) receptor 1 (Knops blood group) |
45 | 1399 | 6.7 | 7.6 | 0.1 | 0.2 | 6.834 | 0.0036 | CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
46 | 1435 | 4.2 | 4.2 | 0.0 | 0.1 | -0.879 | 0.4638 | CSF1 | colony stimulating factor 1 (macrophage) |
47 | 1436 | 3.7 | 2.9 | 0.1 | 0.4 | -3.787 | 0.0406 | CSF1R | colony stimulating factor 1 receptor |
48 | 1437 | 2.3 | 2.3 | 0.0 | 0.0 | 0.420 | 0.7020 | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
49 | 1440 | 2.7 | 2.6 | 0.2 | 0.1 | -0.180 | 0.8679 | CSF3 | colony stimulating factor 3 (granulocyte) |
50 | 6387 | 7.9 | 8.5 | 0.3 | 0.3 | 2.040 | 0.1110 | CXCL12 | chemokine (C-X-C motif) ligand 12 |
51 | 54205 | 10.8 | 10.8 | 0.4 | 0.3 | 0.041 | 0.9690 | CYCS | cytochrome c, somatic |
52 | 114757 | 13.4 | 13.0 | 0.1 | 0.2 | -2.755 | 0.0760 | CYGB | cytoglobin |
53 | 1558 | 2.2 | 2.8 | 0.0 | 0.6 | 1.477 | 0.2775 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 |
54 | 4921 | 2.6 | 2.9 | 0.4 | 0.4 | 0.964 | 0.3899 | DDR2 | discoidin domain receptor tyrosine kinase 2 |
55 | 1674 | 8.3 | 7.9 | 0.3 | 0.1 | -2.309 | 0.1312 | DES | desmin |
56 | 1950 | 2.3 | 2.4 | 0.0 | 0.1 | 1.016 | 0.4144 | EGF | epidermal growth factor |
57 | 1956 | 2.9 | 3.3 | 0.2 | 0.1 | 3.112 | 0.0782 | EGFR | epidermal growth factor receptor |
58 | 1999 | 10.5 | 10.5 | 0.1 | 0.7 | 0.018 | 0.9875 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
59 | 2048 | 5.7 | 5.8 | 0.3 | 0.2 | 0.700 | 0.5288 | EPHB2 | EPH receptor B2 |
60 | 2064 | 9.7 | 9.0 | 0.4 | 0.3 | -2.344 | 0.0865 | ERBB2 | erb-b2 receptor tyrosine kinase 2 |
61 | 2120 | 7.0 | 6.7 | 0.2 | 0.2 | -2.086 | 0.1070 | ETV6 | ets variant 6 |
62 | 2125 | 11.0 | 10.9 | 0.1 | 0.1 | -0.593 | 0.5968 | EVPL | envoplakin |
63 | 2158 | 2.3 | 2.3 | 0.0 | 0.0 | 0.072 | 0.9471 | F9 | coagulation factor IX |
64 | 144717 | 7.2 | 7.6 | 0.2 | 0.2 | 2.499 | 0.0694 | FAM109A | family with sequence similarity 109, member A |
65 | 2258 | 4.8 | 6.2 | 0.4 | 0.4 | 4.282 | 0.0135 | FGF13 | fibroblast growth factor 13 |
66 | 2321 | 2.4 | 2.5 | 0.1 | 0.1 | 0.409 | 0.7102 | FLT1 | fms-related tyrosine kinase 1 |
67 | 2335 | 4.0 | 3.7 | 1.6 | 0.6 | -0.245 | 0.8247 | FN1 | fibronectin 1 |
68 | 2309 | 11.3 | 10.7 | 0.1 | 0.2 | -5.665 | 0.0060 | FOXO3 | forkhead box O3 |
69 | 9837 | 11.7 | 12.2 | 0.2 | 0.4 | 2.240 | 0.1160 | GINS1 | GINS complex subunit 1 (Psf1 homolog) |
70 | 11318 | 3.8 | 3.4 | 0.7 | 1.1 | -0.512 | 0.6414 | GPR182 | G protein-coupled receptor 182 |
71 | 2876 | 3.7 | 3.9 | 0.4 | 0.6 | 0.580 | 0.5999 | GPX1 | glutathione peroxidase 1 |
72 | 3014 | 13.3 | 13.7 | 0.1 | 0.2 | 2.466 | 0.0809 | H2AFX | H2A histone family, member X |
73 | 3043 | 2.4 | 2.4 | 0.0 | 0.0 | 0.209 | 0.8450 | HBB | hemoglobin, beta |
74 | 3162 | 7.7 | 10.0 | 0.8 | 0.5 | 4.350 | 0.0183 | HMOX1 | heme oxygenase (decycling) 1 |
75 | 3242 | 3.6 | 3.5 | 0.4 | 0.4 | -0.326 | 0.7608 | HPD | 4-hydroxyphenylpyruvate dioxygenase |
76 | 3265 | 10.7 | 10.7 | 0.2 | 0.4 | -0.278 | 0.8001 | HRAS | Harvey rat sarcoma viral oncogene homolog |
77 | 3292 | 8.9 | 8.4 | 0.1 | 0.1 | -8.250 | 0.0016 | HSD17B1 | hydroxysteroid (17-beta) dehydrogenase 1 |
78 | 3417 | 10.4 | 11.1 | 0.1 | 0.0 | 9.035 | 0.0115 | IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble |
79 | 3458 | 2.4 | 2.3 | 0.1 | 0.0 | -1.013 | 0.3856 | IFNG | interferon, gamma |
80 | 3480 | 12.9 | 12.8 | 0.3 | 0.2 | -0.296 | 0.7828 | IGF1R | insulin-like growth factor 1 receptor |
81 | 3484 | 2.4 | 2.2 | 0.2 | 0.0 | -0.937 | 0.4466 | IGFBP1 | insulin-like growth factor binding protein 1 |
82 | 10320 | 2.4 | 2.4 | 0.1 | 0.1 | -0.009 | 0.9936 | IKZF1 | IKAROS family zinc finger 1 (Ikaros) |
83 | 22806 | 2.4 | 3.9 | 0.0 | 1.3 | 1.979 | 0.1862 | IKZF3 | IKAROS family zinc finger 3 (Aiolos) |
84 | 3593 | 2.5 | 2.7 | 0.1 | 0.2 | 1.200 | 0.3319 | IL12B | interleukin 12B |
85 | 3558 | 2.5 | 2.4 | 0.1 | 0.1 | -0.771 | 0.4998 | IL2 | interleukin 2 |
86 | 246778 | 4.9 | 5.3 | 0.2 | 0.5 | 1.254 | 0.3133 | IL27 | interleukin 27 |
87 | 3559 | 2.3 | 2.3 | 0.1 | 0.0 | -1.010 | 0.4164 | IL2RA | interleukin 2 receptor, alpha |
88 | 3562 | 2.5 | 2.6 | 0.1 | 0.2 | 0.361 | 0.7433 | IL3 | interleukin 3 |
89 | 3565 | 2.5 | 2.6 | 0.2 | 0.2 | 0.616 | 0.5713 | IL4 | interleukin 4 |
90 | 3567 | 3.3 | 3.3 | 0.1 | 0.9 | 0.064 | 0.9547 | IL5 | interleukin 5 |
91 | 3569 | 2.3 | 2.3 | 0.0 | 0.0 | -0.440 | 0.6964 | IL6 | interleukin 6 |
92 | 3630 | 3.6 | 4.1 | 0.4 | 0.4 | 1.716 | 0.1617 | INS | insulin |
93 | 3643 | 8.3 | 9.3 | 0.1 | 0.2 | 8.564 | 0.0056 | INSR | insulin receptor |
94 | 3717 | 7.8 | 9.0 | 0.2 | 0.4 | 5.183 | 0.0187 | JAK2 | Janus kinase 2 |
95 | 3791 | 2.4 | 2.3 | 0.0 | 0.1 | -0.496 | 0.6472 | KDR | kinase insert domain receptor |
96 | 3815 | 2.3 | 2.3 | 0.1 | 0.0 | -0.184 | 0.8629 | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
97 | 3854 | 2.3 | 4.2 | 0.1 | 1.2 | 2.630 | 0.1181 | KRT6B | keratin 6B, type II |
98 | 3939 | 13.5 | 13.5 | 0.2 | 0.3 | 0.040 | 0.9697 | LDHA | lactate dehydrogenase A |
99 | 4214 | 11.6 | 11.1 | 0.1 | 0.1 | -4.921 | 0.0154 | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
100 | 5871 | 7.3 | 7.0 | 0.2 | 0.2 | -1.543 | 0.1986 | MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 |
101 | 1432 | 7.8 | 7.5 | 0.3 | 0.2 | -1.540 | 0.2107 | MAPK14 | mitogen-activated protein kinase 14 |
102 | 5595 | 8.9 | 9.2 | 0.3 | 0.1 | 1.920 | 0.1525 | MAPK3 | mitogen-activated protein kinase 3 |
103 | 4170 | 10.3 | 10.6 | 0.4 | 0.3 | 1.170 | 0.3075 | MCL1 | myeloid cell leukemia 1 |
104 | 4233 | 9.9 | 11.6 | 0.1 | 0.1 | 28.016 | 0.0001 | MET | MET proto-oncogene, receptor tyrosine kinase |
105 | 4313 | 2.5 | 2.6 | 0.1 | 0.2 | 0.907 | 0.4292 | MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
106 | 4353 | 2.7 | 2.3 | 0.3 | 0.0 | -2.005 | 0.1812 | MPO | myeloperoxidase |
107 | 4360 | 2.5 | 2.7 | 0.1 | 0.3 | 1.239 | 0.3031 | MRC1 | mannose receptor, C type 1 |
108 | 2475 | 8.9 | 9.1 | 0.0 | 0.1 | 3.319 | 0.0559 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
109 | 4609 | 8.9 | 8.0 | 0.4 | 0.6 | -2.174 | 0.1053 | MYC | v-myc avian myelocytomatosis viral oncogene homolog |
110 | 4790 | 10.2 | 10.5 | 0.0 | 0.0 | 12.358 | 0.0018 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
111 | 4795 | 12.8 | 12.5 | 0.3 | 0.1 | -1.631 | 0.2349 | NFKBIL1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
112 | 9971 | 2.4 | 2.5 | 0.0 | 0.2 | 0.992 | 0.4216 | NR1H4 | nuclear receptor subfamily 1, group H, member 4 |
113 | 4893 | 11.2 | 11.1 | 0.2 | 0.1 | -0.175 | 0.8734 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog |
114 | 27065 | 2.1 | 2.1 | 0.0 | 0.0 | 0.372 | 0.7400 | NSG1 | neuron specific gene family member 1 |
115 | 10133 | 7.3 | 7.4 | 0.2 | 0.1 | 1.199 | 0.3034 | OPTN | optineurin |
116 | 10038 | 11.1 | 11.8 | 0.3 | 0.3 | 3.112 | 0.0358 | PARP2 | poly (ADP-ribose) polymerase 2 |
117 | 5077 | 2.9 | 3.2 | 0.4 | 0.3 | 1.051 | 0.3563 | PAX3 | paired box 3 |
118 | 5111 | 12.0 | 13.1 | 0.2 | 0.4 | 4.276 | 0.0250 | PCNA | proliferating cell nuclear antigen |
119 | 5154 | 6.2 | 7.5 | 0.3 | 0.4 | 4.563 | 0.0115 | PDGFA | platelet-derived growth factor alpha polypeptide |
120 | 5156 | 2.3 | 2.3 | 0.0 | 0.0 | 0.365 | 0.7443 | PDGFRA | platelet-derived growth factor receptor, alpha polypeptide |
121 | 5159 | 2.3 | 2.3 | 0.0 | 0.0 | 0.990 | 0.3792 | PDGFRB | platelet-derived growth factor receptor, beta polypeptide |
122 | 80055 | 4.9 | 5.1 | 0.5 | 0.3 | 0.618 | 0.5733 | PGAP1 | post-GPI attachment to proteins 1 |
123 | 283871 | 9.2 | 9.5 | 0.2 | 0.4 | 1.469 | 0.2460 | PGP | phosphoglycolate phosphatase |
124 | 5266 | 2.9 | 3.5 | 0.8 | 0.3 | 1.171 | 0.3403 | PI3 | peptidase inhibitor 3, skin-derived |
125 | 55558 | 11.7 | 11.8 | 0.2 | 0.2 | 0.458 | 0.6717 | PLXNA3 | plexin A3 |
126 | 57804 | 14.6 | 13.8 | 0.3 | 0.4 | -2.989 | 0.0453 | POLD4 | polymerase (DNA-directed), delta 4, accessory subunit |
127 | 728378 | 13.3 | 13.4 | 0.3 | 0.1 | 0.452 | 0.6847 | POTEF | POTE ankyrin domain family, member F |
128 | 5468 | 2.3 | 4.0 | 0.0 | 0.5 | 5.713 | 0.0291 | PPARG | peroxisome proliferator-activated receptor gamma |
129 | 7001 | 12.0 | 12.1 | 0.1 | 0.0 | 3.370 | 0.0339 | PRDX2 | peroxiredoxin 2 |
130 | 112476 | 10.8 | 10.5 | 0.2 | 0.2 | -1.846 | 0.1438 | PRRT2 | proline-rich transmembrane protein 2 |
131 | 83886 | 6.2 | 6.5 | 0.4 | 0.5 | 0.724 | 0.5093 | PRSS27 | protease, serine 27 |
132 | 5728 | 10.1 | 9.8 | 0.0 | 0.1 | -3.208 | 0.0714 | PTEN | phosphatase and tensin homolog |
133 | 2185 | 9.1 | 8.2 | 0.0 | 0.4 | -4.284 | 0.0472 | PTK2B | protein tyrosine kinase 2 beta |
134 | 5788 | 2.9 | 3.0 | 0.2 | 0.4 | 0.315 | 0.7747 | PTPRC | protein tyrosine phosphatase, receptor type, C |
135 | 5893 | 7.5 | 7.3 | 0.4 | 0.1 | -0.678 | 0.5624 | RAD52 | RAD52 homolog (S. cerevisiae) |
136 | 5894 | 11.5 | 11.4 | 0.2 | 0.1 | -0.477 | 0.6613 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
137 | 6006 | 4.4 | 4.1 | 0.5 | 0.3 | -0.751 | 0.5024 | RHCE | Rh blood group, CcEe antigens |
138 | 6010 | 2.6 | 3.5 | 0.3 | 0.4 | 3.430 | 0.0353 | RHO | rhodopsin |
139 | 10535 | 13.6 | 13.6 | 0.1 | 0.1 | 0.277 | 0.7967 | RNASEH2A | ribonuclease H2, subunit A |
140 | 6093 | 9.3 | 9.2 | 0.1 | 0.2 | -0.888 | 0.4381 | ROCK1 | Rho-associated, coiled-coil containing protein kinase 1 |
141 | 6098 | 4.4 | 2.6 | 0.3 | 0.5 | -5.609 | 0.0063 | ROS1 | ROS proto-oncogene 1 , receptor tyrosine kinase |
142 | 6198 | 12.0 | 12.2 | 0.2 | 0.2 | 1.256 | 0.2780 | RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
143 | 6238 | 9.5 | 9.5 | 0.1 | 0.1 | 0.013 | 0.9902 | RRBP1 | ribosome binding protein 1 |
144 | 861 | 6.3 | 7.2 | 0.3 | 0.3 | 4.027 | 0.0158 | RUNX1 | runt-related transcription factor 1 |
145 | 6271 | 5.9 | 4.2 | 0.5 | 0.5 | -4.044 | 0.0156 | S100A1 | S100 calcium binding protein A1 |
146 | 9733 | 10.0 | 10.4 | 0.2 | 0.1 | 3.199 | 0.0713 | SART3 | squamous cell carcinoma antigen recognized by T cells 3 |
147 | 29072 | 8.7 | 8.7 | 0.0 | 0.0 | 0.189 | 0.8593 | SETD2 | SET domain containing 2 |
148 | 27352 | 6.3 | 6.1 | 0.2 | 0.4 | -0.782 | 0.4914 | SGSM3 | small G protein signaling modulator 3 |
149 | 9644 | 3.4 | 2.9 | 0.4 | 0.4 | -1.640 | 0.1765 | SH3PXD2A | SH3 and PX domains 2A |
150 | 23411 | 8.8 | 9.8 | 0.2 | 0.3 | 4.479 | 0.0155 | SIRT1 | sirtuin 1 |
151 | 6580 | 2.7 | 2.8 | 0.2 | 0.3 | 0.798 | 0.4724 | SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 |
152 | 6581 | 2.4 | 2.4 | 0.0 | 0.1 | 0.029 | 0.9782 | SLC22A3 | solute carrier family 22 (organic cation transporter), member 3 |
153 | 6579 | 2.5 | 2.7 | 0.1 | 0.3 | 1.041 | 0.3934 | SLCO1A2 | solute carrier organic anion transporter family, member 1A2 |
154 | 23583 | 9.9 | 9.9 | 0.1 | 0.0 | 0.634 | 0.5814 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 |
155 | 6638 | 2.3 | 2.3 | 0.0 | 0.0 | 0.375 | 0.7343 | SNRPN | small nuclear ribonucleoprotein polypeptide N |
156 | 6652 | 8.6 | 9.4 | 0.2 | 0.1 | 8.100 | 0.0088 | SORD | sorbitol dehydrogenase |
157 | 6714 | 6.5 | 7.6 | 0.1 | 0.1 | 13.718 | 0.0002 | SRC | SRC proto-oncogene, non-receptor tyrosine kinase |
158 | 6772 | 8.8 | 11.3 | 0.2 | 0.2 | 14.558 | 0.0002 | STAT1 | signal transducer and activator of transcription 1, 91kDa |
159 | 6774 | 7.9 | 7.4 | 0.2 | 0.1 | -4.219 | 0.0140 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
160 | 6850 | 9.3 | 8.9 | 0.1 | 0.2 | -4.322 | 0.0243 | SYK | spleen tyrosine kinase |
161 | 6865 | 6.3 | 6.3 | 0.2 | 0.0 | 0.372 | 0.7439 | TACR2 | tachykinin receptor 2 |
162 | 6949 | 9.2 | 9.8 | 0.1 | 0.4 | 2.574 | 0.1186 | TCOF1 | Treacher Collins-Franceschetti syndrome 1 |
163 | 55775 | 11.6 | 11.9 | 0.0 | 0.1 | 4.751 | 0.0210 | TDP1 | tyrosyl-DNA phosphodiesterase 1 |
164 | 11011 | 10.3 | 10.3 | 0.1 | 0.1 | 0.133 | 0.9020 | TLK2 | tousled-like kinase 2 |
165 | 7124 | 3.9 | 4.1 | 2.4 | 0.7 | 0.111 | 0.9206 | TNF | tumor necrosis factor |
166 | 7157 | 7.9 | 7.4 | 0.3 | 0.5 | -1.440 | 0.2378 | TP53 | tumor protein p53 |
167 | 7170 | 8.9 | 9.2 | 0.2 | 0.2 | 2.532 | 0.0661 | TPM3 | tropomyosin 3 |
168 | 23430 | 3.5 | 2.3 | 2.2 | 0.1 | -0.976 | 0.4319 | TPSD1 | tryptase delta 1 |
169 | 7187 | 6.6 | 6.6 | 0.3 | 0.3 | 0.039 | 0.9711 | TRAF3 | TNF receptor-associated factor 3 |
170 | 83696 | 11.2 | 10.8 | 0.1 | 0.4 | -1.557 | 0.2423 | TRAPPC9 | trafficking protein particle complex 9 |
171 | 7248 | 7.0 | 6.6 | 0.5 | 0.0 | -1.693 | 0.2299 | TSC1 | tuberous sclerosis 1 |
172 | 7253 | 2.2 | 2.2 | 0.0 | 0.0 | -0.897 | 0.4388 | TSHR | thyroid stimulating hormone receptor |
173 | 8615 | 12.1 | 11.6 | 0.1 | 0.1 | -7.027 | 0.0028 | USO1 | USO1 vesicle transport factor |
174 | 7422 | 8.5 | 8.5 | 0.5 | 0.2 | 0.009 | 0.9937 | VEGFA | vascular endothelial growth factor A |
175 | 7431 | 4.9 | 6.7 | 0.5 | 0.1 | 6.548 | 0.0153 | VIM | vimentin |
176 | 7490 | 2.4 | 2.3 | 0.1 | 0.0 | -1.205 | 0.2991 | WT1 | Wilms tumor 1 |
177 | 331 | 9.5 | 9.9 | 0.1 | 0.2 | 2.825 | 0.0546 | XIAP | X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase |
178 | 7532 | 13.5 | 13.9 | 0.1 | 0.1 | 5.532 | 0.0125 | YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
179 | 22882 | 9.6 | 10.2 | 0.1 | 0.3 | 3.424 | 0.0581 | ZHX2 | zinc fingers and homeoboxes 2 |